Zhejiang Xianju Pharmaceutical (002332.SZ) Earnings Analysis

Zhejiang Xianju Pharmaceutical (002332.SZ) next reports earnings on 2026-08-20. Trailing P/E 20.57.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002332.SZ next report earnings?

Next earnings date2026-08-20
Consensus EPS estimaten/a
Revenue estimaten/a

002332.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-230.0434 CNYn/an/an/a
2025-03-310.1456 CNYn/an/an/a
2024-10-250.1925 CNYn/an/an/a
2024-08-260.1907 CNYn/an/an/a

002332.SZ valuation and analyst view

Trailing P/E20.57
Trailing EPS0.4039 CNY
Price / book1.37
Dividend yield3.58%
Market cap8.26B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Zhejiang Xianju Pharmaceutical (002332.SZ)'s next earnings date?

Zhejiang Xianju Pharmaceutical is next scheduled to report on 2026-08-20.

Did 002332.SZ beat earnings last quarter?

Consensus estimate data was not available for 002332.SZ's 2026-04-23 report.

What is 002332.SZ's current P/E ratio and EPS?

002332.SZ trades at a trailing P/E of 20.57 on trailing EPS of 0.4039028837531011 CNY.

What do analysts rate 002332.SZ?

002332.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.